The voice for compounding pharmacy | June 19, 2019
FDA's overreach will harm compounding pharmacies and the patients they serve
In a June 19 op-ed in the publication STAT, IACP executive vice president Scott Brunner says FDA's overreach will harm compounding pharmacies and the patients they serve. He writes:
America's compounding pharmacists and pharmacy owners are not seeking to operate in an unregulated or underregulated environment. And they don't want incidents like the New England Compounding Center tragedy to ever happen again. The fact is that this industry - and the patients it serves - benefit from a strong regulatory framework.
But it needs to be a practical framework, too: one that recognizes there is a proper role for compounding pharmacists in serving patients. One that assures that patients have continued access to safe, affordable compounded medications. And one that doesn't throw out the baby with the bathwater.
